Crinetics Pharmaceuticals (CRNX)

KSIX Media Holdings, Inc., Mar Ked Mineral Exploration, Inc., NORTH AMERICAN ENERGY RESOURCES, INC., North American Energy Resources, Inc., Surge Holdings, Inc.

SEC CIK

0001658247

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

CRNX stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$70.00

Low target

$55.00

High target

$81.00

Latest filings (excl ownership)

View all

8-K

Regulation FD Disclosure

14 Jan 25

8-K

Meaningful Improvements Demonstrated in Multiple Clinical Signs and Symptoms of CAH Affecting Patient Health

10 Jan 25

8-K

Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

16 Dec 24

8-K

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

12 Nov 24

Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results

12 Nov 24

8-K

Departure of Directors or Certain Officers

16 Oct 24

8-K

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

9 Oct 24

424B5

Prospectus supplement for primary offering

9 Oct 24

424B5

Prospectus supplement for primary offering

8 Oct 24

Transcripts

View all

CRNX

Earnings call transcript

2024 Q3

12 Nov 24

CRNX

Earnings call transcript

2024 Q2

8 Aug 24

CRNX

Earnings call transcript

2024 Q1

9 May 24

CRNX

Earnings call transcript

2023 Q4

28 Feb 24

CRNX

Earnings call transcript

2020 Q4

31 Mar 21

Latest ownership filings

View all

Notice of proposed sale of securities

Richard Scott Struthers

4 Dec 24

144

Notice of proposed sale of securities

2 Dec 24

Jeff E. Knight

26 Nov 24

Financial summary

Financial statements Chart CRNX financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	318.57 mm	318.57 mm	318.57 mm	318.57 mm	318.57 mm	318.57 mm
Cash burn (monthly)	(no burn)	(no burn)	29.27 mm	25.56 mm	20.94 mm	16.65 mm
Cash used (since last report)	n/a	n/a	117.72 mm	102.83 mm	84.23 mm	66.98 mm
Cash remaining	n/a	n/a	200.85 mm	215.74 mm	234.34 mm	251.59 mm
Runway (months of cash)	n/a	n/a	6.9	8.4	11.2	15.1

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

CRNX institutional ownership history Ownership history

93.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	233	235	-0.9%
Opened positions	28	55	-49.1%
Closed positions	30	19	+57.9%
Increased positions	95	97	-2.1%
Reduced positions	72	56	+28.6%

13F shares	Current	Prev Q	Change
Total value	3.87 tn	3.31 tn	+16.9%
Total shares	86.22 mm	84.19 mm	+2.4%
Total puts	44.20 k	196.80 k	-77.5%
Total calls	23.30 k	268.00 k	-91.3%
Total put/call ratio	1.9	0.7	+158.3%

Largest owners	Shares	Value	Change
BlackRock	6.55 mm	$334.70 bn	NEW
Vanguard	6.29 mm	$321.30 bn	+39.3%
Driehaus Capital Management	5.89 mm	$300.74 bn	-3.7%
T. Rowe Price	4.94 mm	$252.68 mm	+12.2%
Wellington Management	4.46 mm	$227.89 bn	-3.5%
FMR	4.46 mm	$227.69 bn	+8.8%
EcoR1 Capital	4.29 mm	$219.12 bn	+3.2%
STT State Street	2.84 mm	$145.05 bn	+0.9%
Jennison Associates	2.79 mm	$142.75 bn	+0.5%
Paradigm Biocapital Advisors	2.52 mm	$128.60 bn	+0.1%

Largest transactions	Shares	Bought/sold	Change
BlackRock	6.55 mm	+6.55 mm	NEW
BLK BlackRock	0.00	-6.23 mm	EXIT
Vanguard	6.29 mm	+1.77 mm	+39.3%
Siren, L.L.C.	1.31 mm	+1.31 mm	NEW
Artal	0.00	-1.07 mm	EXIT
Perceptive Advisors	724.70 k	-751.51 k	-50.9%
Farallon Capital Management	1.16 mm	+665.00 k	+133.8%
Pictet Asset Management Holding	908.15 k	+607.28 k	+201.8%
T. Rowe Price	4.94 mm	+538.30 k	+12.2%
BEN Franklin Resources	1.39 mm	+528.69 k	+61.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

CRNX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
10 Jan 25	Isabel Kalofonos	Stock Option Common Stock	Grant	Acquire A	No	No	40.59	100,000	4.06 mm	100,000
7 Jan 25	Dana Pizzuti	Common Stock	Option exercise	Acquire M	No	No	19.64	2,500	49.10 k	31,748
7 Jan 25	Dana Pizzuti	Stock Option Common Stock	Option exercise	Dispose M	No	No	19.64	2,500	49.10 k	18,500
3 Jan 25	Dana Pizzuti	Common Stock	Sell	Dispose S	No	Yes	52.09	15,000	781.35 k	29,248
3 Jan 25	Dana Pizzuti	Common Stock	Option exercise	Acquire M	No	No	16.89	15,000	253.35 k	44,248
3 Jan 25	Dana Pizzuti	Stock option Common Stock	Option exercise	Dispose M	No	No	16.89	15,000	253.35 k	124,042
16 Dec 24	Stephen F. Betz	Common Stock	Option exercise	Acquire M	No	No	1.91	2,331	4.45 k	71,358
16 Dec 24	Stephen F. Betz	Stock Option Common Stock	Option exercise	Dispose M	No	No	1.91	2,331	4.45 k	180,039
20 Nov 24	Stephen F. Betz	Common Stock	Other	Acquire J	No	No	14.98	451	6.76 k	71,358
20 Nov 24	Marc Wilson	Common Stock	Other	Acquire J	No	No	14.98	473	7.09 k	111,565